Molecular insights into cell toxicity of a novel familial amyloidogenic variant of &#946;2-microglobulin by Leri, Manuela et al.
Molecular insights into cell toxicity of a novel familial
amyloidogenic variant of b2-microglobulin
Manuela Leri a, Francesco Bemporad a, Reinier Oropesa-Nu~nez b, Claudio Canale b,
Martino Calamai c, d, Daniele Nosi e, Matteo Ramazzotti a, Sofia Giorgetti f, Francesco S. Pavone c,
Vittorio Bellotti f, g, Massimo Stefani a, h, Monica Bucciantini a, h, *
a Dipartimento di Scienze Biomediche, Sperimentali e Cliniche ‘Mario Serio’, Universita degli Studi di Firenze, Firenze, Italy
b Dipartimento di Nanofisica, Istituto Italiano di Tecnologia, Genova, Italy
c European Laboratory for Non-linear Spectroscopy (LENS), Universita degli Studi di Firenze, Sesto Fiorentino, Italy
d National Institute of Optics, Consiglio Nazionale delle Ricerche (CNR), Firenze, Italy
e Dipartimento di Medicina Sperimentale e Clinica, Universita degli Studi di Firenze, Firenze, Italy
f Dipartimento di Medicina Molecolare, Istituto di Biochimica, Universita degli Studi di Pavia, Pavia, Italy
g Wolfson Drug Discovery Unit, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine,
Royal Free Campus University College London, London, UK
h Centro Interuniversitario per lo Studio delle Malattie Neurodegenerative (CIMN), Firenze, Italy
Received: November 2, 2015; Accepted: February 10, 2016
Abstract
The first genetic variant of b2-microglobulin (b2M) associated with a familial form of systemic amyloidosis has been recently described. The
mutated protein, carrying a substitution of Asp at position 76 with an Asn (D76N b2M), exhibits a strongly enhanced amyloidogenic tendency to
aggregate with respect to the wild-type protein. In this study, we characterized the D76N b2M aggregation path and performed an unprece-
dented analysis of the biochemical mechanisms underlying aggregate cytotoxicity. We showed that, contrarily to what expected from other
amyloid studies, early aggregates of the mutant are not the most toxic species, despite their higher surface hydrophobicity. By modulating gan-
glioside GM1 content in cell membrane or synthetic lipid bilayers, we confirmed the pivotal role of this lipid as aggregate recruiter favouring
their cytotoxicity. We finally observed that the aggregates bind to the cell membrane inducing an alteration of its elasticity (with possible func-
tional unbalance and cytotoxicity) in GM1-enriched domains only, thus establishing a link between aggregate-membrane contact and cell
damage.
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Introduction
b2-microglobulin (b2M) is a 99 residue-long human protein belonging
to the major histocompatibility complex class I (MHC I). The protein
acts as a chaperone during the assembly of MHC I quaternary struc-
ture, an event that is required for antigen presentation [1]. Struc-
turally, b2M is an all-b protein with seven anti-parallel b-strands
organized into two b-sheets and stabilized by a single disulphide
bridge [2]. In addition to its physiological function, much clinical
interest has been drawn to b2M as its increased serum levels and
misfolding have been linked to a pathological condition known as
dialysis-related amyloidosis (DRA) [3]. Normally, once released from
the quaternary structure of MHC I, b2M is cleared in the proximal
tubules of the kidneys. However, the serum concentration of b2M in
patients undergoing dialysis rises from normal levels (1–2 mg/l) to
as much as 50–70 mg/l [3, 4]. Enhanced concentration, in conjunc-
tion with other factors such as the presence of Cu2+ ions [5, 6], colla-
gen [7], glycosaminoglycans [8] and other factors [9], results in b2M
misfolding and eventually to the formation of amyloid aggregates that
deposit mainly into joints.
Although conversion of wild-type b2M into amyloid fibrils is diffi-
cult to achieve in vitro under physiological conditions, many recombi-
nant b2M variants have been investigated, and hypotheses about the
mechanisms underlying protein fibrillogenesis have been put forward
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[3]. The proposed aggregation mechanism of b2M involves the forma-
tion of an amyloidogenic native-like conformation, usually referred to
as NT state, which, albeit being globally folded, bears the His31-Pro32
peptide bond in the non-native trans configuration [3, 10]. This view
has been confirmed by recent data showing that b2M stability, (un)-
folding and aggregation properties are all influenced by the kinetics
and equilibrium of Pro32 cis-trans isomerization [11]. Until recently,
no natural pathological mutations of b2M were recognized. However, a
recent report described a French kindred carrying a heterozygous point
mutation in the gene encoding b2M [4] which results in the replace-
ment of aspartate 76 with an asparagine (D76N b2M). The pathogenic
protein was aggressively fibrillogenic in vitro under conditions where
the stability of the wild-type protein is unaffected, prompting a re-eva-
luation of previously hypothesized mechanisms of b2M fibrillogenesis.
Individuals of this family suffered a complex set of clinical symptoms,
including bowel dysfunction with chronic diarrhoea and sicca syn-
drome, weight loss and postural dizziness [4]. 123I-human serum amy-
loid protein (SAP) scans and postmortem examination of affected
people revealed the presence of amyloid deposits in the spleen, liver,
heart, peripheral nerves, salivary and adrenal glands. Importantly, the
D76N b2M present in amyloid fibrils extracted from patients consisted
only of the full-length variant without any truncated form. Moreover, in
contrast to DRA patients, all the members of this family displayed nor-
mal circulating concentrations of b2M and normal renal function. Con-
sequently, the pathological condition of these patients was described
as a hereditary systemic amyloidosis associated with D76N b2M [4].
The experimental evidence described above points towards a high
amyloidogenic potential of D76N b2M. In fact, when incubated in vitro
at a protein concentrations 20-fold higher than those found in patients
under dialysis, wild-type b2M remains predominantly monomeric for
several months [12]. Under these conditions, b2M aggregation can be
induced only by the aforementioned cofactors or at low pH and in the
presence of co-solvents such as 2,2,2-trifluoroethanol [3]. By con-
trast, D76N b2M rapidly aggregates when incubated at 37°C at physi-
ological pH and ionic strength; under these conditions, the
aggregation can be accelerated by agitation that enhances the air–wa-
ter interface. Atomic force microscopy images showed that amyloid
fibrils grown from D76N b2M are already present after 8 hrs since
the beginning of the aggregation process [10]. The crystal structure
of the D76N variant at 1.40 A resolution provided clues to explain its
reduced stability and its increased fibrillogenic potential. The amide
group of Asn76 establishes a new hydrogen bond with Tyr78, which
moves closer to residue 76 providing a hydrogen bond to the amide
nitrogen of Thr73. In addition, the theoretical isoelectric point of the
mutant shifts from 6.05 to 6.40 due to the loss of the negative charge
of Asp76 [4]. In an attempt to get mechanistic insight into the aggre-
gation properties of D76N b2M, it was found that although the solu-
tion structure of the mutant does not differ significantly from that of
the wild-type protein, such variant is strongly destabilized when com-
pared with the latter, with denaturation free energy values of
5.7  0.4 and 3.00  0.15 kcal/mol for wild-type and D76N b2M,
respectively [10]. Such destabilization arises from accelerated unfold-
ing and slower refolding. NMR experiments were consistent with such
measurements, revealing that D76N b2M possesses enhanced molec-
ular dynamics and loss of rigidity. Intriguingly, a set of experiments
on folding/unfolding kinetics showed that the amyloidogenic NT state
is significantly more populated in the variant. Indeed, the in vitro equi-
librium concentration of such conformation, measured at physiologi-
cal pH and in the absence of denaturants, appears increased in the
case of the variant, with values of 4.8  3.0% and 25  9.0% for
wild-type and D76N b2M, respectively [10].
Although the pieces of evidence described above provide valuable
information concerning the in vitro stability and aggregation propen-
sity of D76N b2M, additional information is still required to link these
data to amyloid-related toxicity of this variant. In this article, we
exploited a battery of complementary biophysical tools to characterize
the species transiently populated during D76N aggregation. The abil-
ity of such aggregates to interact with model membranes bearing dif-
ferent lipid composition was also evaluated. The outcome of these
experiments was compared with cell biology studies aimed at investi-
gating the mechanisms of cytotoxicity of the different aggregation
states of D76N b2M. These results provide an unprecedented charac-
terization of the pathway spanning from protein misfolding to the cell
dysfunctions underlying b2M hereditary systemic amyloidosis.
Materials and methods
Preparation of D76N aggregates
D76N b2M was expressed and purified as previously reported [4, 10].
The aggregation reaction was initiated starting from the freeze-dried
protein. Briefly, the protein was dissolved in PBS (Sigma-Aldrich, St.
Louis, MO, USA). At time 0 of the aggregation reaction, the protein
solution was centrifuged for 5 min. at 13,200 9 g and filtrated through
0.02 lm nanofilters (Whatman Inc., Amersharm, UK) to eliminate possi-
ble aggregation seeds. The resulting supernatant was diluted to a pro-
tein concentration of 20 lM. The latter was determined by measuring
the absorption at 280 nm, using a molar extinction coefficient of
19,940 per M/cm, a 1.0-mm path-length cell and a Jasco V-630 UV-
visible spectrophotometer (Tokyo, Japan). A 300 ll of the obtained
solution was incubated in a 1.5-ml eppendorf tube lying in horizontal
position, under vigorous shaking at 37°C.
Far-UV circular dichroism spectroscopy
A far-UV circular dichroism (CD) spectrum of 0.2 mg/ml D76N b2M
was acquired at 25°C in PBS. The spectrum was collected over the
190–250 nm wavelength range using a Jasco-810 Spectropolarimeter
equipped with a thermostated cell holder attached to a Thermo Haake
C25P water bath (Karlsruhe, Germany). A 1.0-mm path-length cell was
used. The spectrum was blank subtracted and converted to mean
residue ellipticity per residue (h).
Dinamic light scattering
Size distribution analysis was carried out at 25°C using a Malvern Zeta-
sizer Nano S dynamic light scattering (DLS) device (Malvern, Worcester-
shire, UK) on 20 lM D76N b2M samples. Each sample was analysed
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considering the refraction index and viscosity of its dispersant. A 10-mm
reduced volume plastic cell was used. The acquired data were compared
with the theoretical hydrodynamic radius expected for folded polypeptide
chains, calculated as Rh
folded = 4.92N0.285, where N is the number of
residues and Rh
folded is the hydrodynamic radius expressed inA [13].
Congo Red absorbance
Congo Red (CR; Sigma-Aldrich) spectra were recorded at 25°C in the
presence of D76N b2M. For any time-point, three spectra were acquired
containing (i) 60 ll of the aggregating protein solution and 440 ll of a
solution containing 20 lM CR (spectrum 1), (ii) 60 ll of PBS devoid of
protein and 440 ll of buffer containing 20 lM CR (spectrum 2) and
(iii) 60 ll of protein and 440 ll of PBS in the absence of CR (spectrum
3). The spectra were recorded from 400 to 700 nm using a Jasco V-
630 spectrophotometer and a 5.0-mm reduced volume quartz cell. The
difference spectra were obtained by subtracting spectrum 2 and spec-
trum 3 from spectrum 1.
Thioflavin T fluorescence
Aliquot of 62 ll of the aggregation solution was mixed with 438 ll of a
solution containing 25 lM thioflavin T ThT dissolved in a 25 mM phos-
phate buffer, pH 6.0. Fluorescence spectra from 450 to 600 nm were
acquired at 25°C in a 2 9 10 mm quartz cuvette using a Perkin-Elmer LS
55 spectrofluorimeter (Waltham, MA, USA) equipped with a thermostated
cell holder attached to a Haake F8 water bath. Excitation wavelength was
440 nm. The ThT fluorescence spectrum obtained under the same condi-
tions without D76N b2M was subtracted from that acquired in the pres-
ence of the dye. The data were fitted to an empirical sigmoid function [14]:
F ¼ F0 þ A=f1þ exp½kaggðt1=2  tÞg (1)
where F is the measured fluorescence, F0 is the fluorescence at the
beginning at the reaction, t1/2 is the midpoint of the reaction, kagg is the
apparent aggregation rate and A is the jump in fluorescence upon
aggregation. The length of the lag-phase tlag can be calculated as
tlag = t1/2  2/(kagg) [14].
ANS fluorescence
Samples containing aggregating D76N b2M at 20 lM were investigated
for their ability to bind 8-anilinonaphthalene-1-sulfonic acid (ANS; Sigma-
Aldrich). Briefly, 100 ll of the aggregation solution were mixed with
500 ll of a solution containing 120 lM ANS in PBS. Then, the fluores-
cence spectra were recorded in the 400–600 nm range using the same
equipment and cuvette described above for the ThT fluorescence experi-
ments. Excitation wavelength was 370 nm. The data were analysed by
subtracting blank spectra consisting of the dye in PBS without protein.
Transmission electron microscopy
Transmission electron microscope (TEM) imaging was carried out as
follows. Briefly, 5.0-ll aliquots of D76N b2M were withdrawn at differ-
ent aggregation times, loaded onto a formvar/carbon-coated 400 mesh
nickel grids (Agar Scientific, Stansted, UK) and negatively stained with
2.0% (w/v) uranyl acetate (Sigma-Aldrich). The grid was air-dried and
examined using a JEM 1010 TEM at 80-kV excitation voltage.
Cell culture and cell viability assay
The SH-SY5Y cells were cultured at 37°C in complete medium [50%
HAM, 50% DMEM, 10% foetal bovine serum (FBS), 3.0 mM glutamine,
100 units/ml penicillin and 100 lg/ml streptomycin], in a humidified,
5.0% CO2 incubator. All the materials used for cell culture were from
Sigma. HL-1 mouse atrial myocytes were obtained from Dr W. C. Clay-
comb (Louisiana State University Health Science Center, New Orleans, LA,
USA) and grown in T25, gelatin/fibronectin-coated flasks, as previously
described [15]. The cells were maintained in Claycomb Medium (SAFC,
Saint Louis, MO, USA) supplemented with 10% FBS containing 2.0 mM
L-glutamine, 0.1 mM noradrenaline and 100 U/ml penicillin-streptomycin
(Sigma-Aldrich). Every 3 days, the cells (70–90% confluent) were
detached and re-plated at a 1:3 dilution in a new T25 flask or in 96-well
plates and used for measurements. Samples containing aggregating
D76N b2M were administered to cells at a final concentration of 5.0 lM.
The toxicity of the different forms of D76N b2M aggregates was assessed
by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) (Sigma-Aldrich) reduction inhibition assay based on the protocol
described for the first time by Mosmann [16]. In all MTT experiments, the
cells were plated at a density of 10,000 cells per well on 96-well plates in
100-ll culture medium. After 48 hrs, the cells were treated with the
aggregates for 24 hrs and then incubated for a further 2.0 hrs with
100 ll of DMEM without phenol red, containing 0.5 mg/ml MTT. After
2.0 hrs, 100 ll of cell lysis buffer (20% SDS, 50% N,N-dimethylforma-
mide, pH 4.7) was added to each well and the samples were incubated at
37°C to allow complete lysis. The absorbance values of blue formazan
were determined at 595 nm with an automatic plate reader (Bio-Rad,
Milan, Italy). The final absorption values were calculated by averaging
three independent measurements of each sample and subtracting from
this the average of the blank solution, consisting of 100 ll of MTT solu-
tion and 100 ll of lysis buffer (20% SDS, 50% N,N-dimethylformamide).
All data were expressed as mean  S.D.
Reactive oxygen species measurement
The intracellular levels of reactive oxygen species (ROS) were deter-
mined using the fluorescent probe 20,70–dichlorofluorescin diacetate,
acetyl ester (CM-H2 DCFDA; Sigma-Aldrich). CM-H2 DCFDA is a cell-per-
meant indicator for ROS that is not fluorescent until removal of the
acetate groups by intracellular esterases and subsequent oxidation. The
latter can be detected by monitoring the increase in fluorescence at
538 nm. The SH-SY5Y and HL-1 cells were plated at a density of
10,000 cells per well on 96-well plates. After 24 hrs of cell exposure to
the aggregates, 10 lM DCFDA in DMEM without phenol red was added.
After 30 min, the fluorescence values at 538 nm were detected by Fluo-
roscan Ascent FL (Thermo-Fisher, Illkinch, France).
Cytosolic calcium levels
The cytosolic levels of free Ca2+ were measured using the fluorescent
probe Fluo-3 acetoxymethyl ester (Fluo-3 AM; Invitrogen, Monza, Italy).
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Subconfluent SH-SY5Y cells cultured on glass coverslips were incu-
bated at 37°C for 5.0 min with 5.0 lM Fluo-3 AM prior to exposure to
D76N b2M aggregates for 1.0 hr. At the end of the incubation, the cells
were fixed in 2.0% buffered paraformaldehyde for 10 min. Cell fluores-
cence was visualized using a confocal Leica TCS SP5 scanning micro-
scope (Leica, Mannheim, Germany) equipped with a HeNe/Ar laser
source for fluorescence measurements. The observations were per-
formed using a Leica Plan 7 Apo X63 oil immersion objective, suited
with optics for DIC acquisition. Cells from five independent experiments
and three areas (about 20 cells/area) per experiment were analysed.
The fluorescence intensity of Fluo3-AM was analysed by using ImageJ
software (National Institutes of Health, Bethesda, MD, USA) and
expressed as arbitrary units.
Cell death detection
Cell apoptosis was detected by the Annexin V-fluorescein isothiocyanate
(FITC) Apoptosis detection kit (Sigma-Aldrich). A propidium iodide (PI)
solution containing Annexin V-FITC was used to discriminate viable
from apoptotic and secondary necrotic cells. Briefly, after a 24-hr treat-
ment with the most toxic D76N b2M aggregates, the cells were incu-
bated with Annexim V-FITC and PI for 10 min, at room temperature.
Then, the cells were analysed by flow cytometry. Annexin V-FITC was
detected as a green fluorescence at 514 nm and PI was detected as a
red fluorescence at 617 nm.
Confocal immunofluorescence
Subconfluent SH-SY5Y and HL-1 cells grown on glass coverslips were
treated for 24 hrs with the different D76N b2M aggregates grown for
various time lengths, at 5.0 lM final concentration. After incubation,
the cells were washed with PBS; then, GM1 labelling at the cell surface
was performed by incubating the cells with 10 ng/ml CTX-B Alexa488 in
complete medium for 10 min at room temperature. Finally, the cells
were fixed in 2.0% buffered paraformaldehyde for 10 min., permeabi-
lized by treatment with a solution containing 50% acetone and 50%
ethanol for 4.0 min. at room temperature, washed with PBS and
blocked with PBS containing 0.5% BSA and 0.2% gelatine. After block-
ing, the cells were incubated for 1.0 hr at room temperature with a rab-
bit polyclonal antibody raised against b2M (Abcam, Cambridge, UK)
diluted 1:600 in the blocking solution and washed with PBS for 30 min.
under stirring. The immunoreaction was revealed with Alexa 568-conju-
gated anti-rabbit secondary antibody (Invitrogen) diluted 1:100 in PBS.
Finally, the cells were washed twice in PBS and once in water to
remove non-specifically bound antibodies. Cell fluorescence was visual-
ized using a confocal Leica TCS SP5 scanning microscope (Leica)
equipped with a HeNe/Ar laser source for fluorescence measurements.
The observations were performed using a Leica Plan 7 Apo X63 oil
immersion objective, suited with optics for DIC acquisition.
GM1 depletion
To reduce cell membrane GM1, the glucosylceramide synthase of the
plated cells was inhibited by supplementing the cell culture medium
with 25 lM D-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propa-
nol (PDMP; Matreya, LLC, Bellefonte, PA, USA) for 72 hrs at 37°C in
complete medium as previously described [17]. The same pre-treat-
ment was used for cells subjected both to MTT assay and to
immunofluorescence imaging. Cells from five independent experiments
and three areas (about 20 cells/area) per experiment were analysed.
The fluorescence intensity of CTX-B Alexa488 was analysed by using
ImageJ software (National Institutes of Health) and expressed as
arbitrary units.
Single particle imaging and tracking
Quantum dots (QDs) labelling and live imaging have been extensively
described [18]. Briefly, living cells previously exposed to D76N b2M
aggregates were incubated at 37°C in phenol red-free Leibovitz’s L-15
medium 10% FBS with anti-b2M antibodies (1:1000) for 20 min., then
for 5.0 min. with antimouse Alexa 488 (1:500) and 10 lg/ml biotiny-
lated CTX-B and finally with streptavidin QDs (Invitrogen) in QD binding
buffer for 1.0 min. QDs emitting at 655 nm were used at a 1:10,000
dilution. The cells were monitored with a custom-made wide-field epiflu-
orescence microscope equipped with an oil-immersion objective (Nikon
Plan Apo TIRF 609/1.45), a Reliant 150 Select argon ion laser (excita-
tion line 488 nm) and a heating chamber. A FF499-Di01-25 dichroic
and FF01-655/15-25 (for QDs) and FF01-530/43-25 (for Alexa 488)
emission filters (Semrock) were used; 250 or 100 consecutive frames
were acquired with an integration time of 10 msec., with an Electron
Multiplying Charge-Coupled iXon Ultra camera (Andor, Belfast, UK).
Recording sessions did not last more than 30 min. Tracking of single
QDs, identified according to their fluorescence intermittence, was per-
formed with MATLAB (MathWorks, Natick, MA, USA) using a macro
that accounts for blinking in the fluorescence signal [18–20]. In brief,
the method consisted of two main steps, applied consecutively to each
frame of the sequence. First, the fluorescent spots were detected by
cross-correlating the image with a Gaussian model of the Point Spread
Function. A least-squares Gaussian fit was applied (around the local
maximum above a threshold) to determine the centre of each spot with
a spatial accuracy of 10–20 nm (depending on the signal-to-noise
ratio). Second, QD trajectories were assembled automatically by linking,
frame by frame, the centres of the fluorescent spots likely coming from
the same QD. The association criterion was based on the assumption of
free Brownian diffusion and took into account short blinking events.
After processing, a manual association step was performed, in which
QD trajectories of maximal length were assembled from smaller frag-
ments separated by longer blinking events that were not taken into
account by the automatic linking procedure. A high concentration of
pentavalent B subunit of cholera toxin can in principle induce cross-link-
ing of GM1. For SPT experiments, however, we incubated the cells with
CTX-B for times shorter than for standard immunolabelling experiments,
thus obtaining a lower level of labelling. The concentration of strep-QDs
was largely in excess with respect of biotin-CTX-B. Most of, if not all,
the CTX-B molecules bound to the plasma membrane are therefore
expected to be labelled.
Quantitative analysis of diffusion coefficient
The mean square displacement (MSD) analysis allows to calculate the
initial diffusion coefficient (D) of each particle [18–21]. Briefly, physical
parameters can be extracted from each trajectory (x(t), y(t)) by comput-
ing the MSD [22], determined from the following formula:
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MSDðndtÞ ¼ 1
N  n
XNn
i¼1
XðiþnÞ  Xi
 2þ YðiþnÞ  Yi
 2h i
where xi and yi are the coordinates of a particle on frame i, dt is the
time between two successive frames, N is the total number of frames
of the trajectory and ndt is the time interval over which the displace-
ment is averaged. This function enables the analysis of the lateral
dynamics on short- (initial diffusion coefficient) and long- (types of
motion) time scales. Different types of motion can be distinguished
from the time dependence of the MSD [21]. The initial diffusion coeffi-
cient (D) is determined by fitting the initial 2–5 points of the MSD
against time plot with MSD(t) = 4D2-5 t + b. The cumulative probability
C(d) of D defines the probability that D is less than d. We compared
cumulative probability distributions and median instead of mean values
because D values were spread over four orders of magnitude. The
Images were thresholded with ImageJ software, creating binary masks
corresponding to amyloid aggregates.
Synthetic lipid vesicle preparation
1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC,18:1), sphingomyelin
(SM) (brain, porcine) and ganglioside GM1 (brain, ovine- sodium salt)
were purchased from Avanti Polar Lipids (Alabaster, Alabama, USA);
cholesterol (Chol), chloroform and methanol were purchased from
Sigma-Aldrich. Two different mixtures were prepared, containing DOPC:
SM at 2:1 molar ratio, a fixed, 1.0%, molar percentage of cholesterol
and a variable percentage of 5.0% GM1, when present. To prepare the
liposomes in solution, we dissolved the phospholipid powder in chloro-
form/methanol (2:1) according the desired composition and gently
evaporated the mixture to dryness under a nitrogen flux. Aliquots were
stored overnight under vacuum and resuspended in Milli-Q water to
form multilamellar vesicles. Multilamellar vesicles suspensions were
pre-sonicated at 60°C for 1.0 hr and then extruded 11 times through
polycarbonate membrane with 100 nm pores using a commercial extru-
der (Avanti Polar Lipids) at 60°C. The suspensions were left to cool at
room temperature and the large unilamellar vesicles suspensions so
obtained were diluted 10-fold in Milli-Q water; then 40 ll of each sus-
pension and 10 ll of 10 mM CaCl2 solution were deposited on a
1.0 cm 9 1.0 cm freshly cleaved mica substrate. In order to get uni-
form bilayer coverage, the samples were incubated for 15 min. at 60°C
after 10 min. storage at room temperature; then the samples were kept
at room temperature in a close chamber with 100% relative humidity.
Before atomic force microscopy (AFM) measurements, SLBs were
gently rinsed three times with Milli-Q water to remove excess vesicles
from the liquid subphase.
AFM imaging and elasticity measurements
AFM images and indentation measurements were performed by using a
Nanowizard III (JPK Instruments, Berlin, Germany) mounted on an Axio
Observer D1 (Carl Zeiss, Wetzlar, Germany). inverted optical microscope.
V-shaped DNP silicon nitride cantilevers (Bruker, Billerica, MA, USA), with
a nominal spring constant 0.06 N/m, resonance frequency in air in the 40–
70 kHz range and tip typical curvature radius of 20–60 nm were used. The
actual spring constant of each cantilever was determined in situ, using the
thermal noise method. D76N b2M aggregates at different times of aggrega-
tion (1, 24, 72 and 144 hrs) were administered to the sample under the
AFM head at a 5.0-lM final concentration and let incubating for 20 min.
before further measurements. Before injection, the AFM tip was lifted up
60 lm from the sample. Quantitative Imaging mode (QI–JPK Instruments)
was used to determine sample topography and elasticity (Young’s Modu-
lus) before and after the administrations of the protein aggregates. QI is
based on the acquisition of a large set of force–distance curves and on the
reconstruction of sample topography from the tip position at the specific
force load. Local mechanical properties of the sample can be extracted
from the analysis of the acquired curves. QI images deriving from
128 9 128 force–distance (FD) curves were acquired on different samples
before and after protein administration, with maximum force load of
1.0 nN. For each curve, the tip speed was 25 lm/sec. and the curve length
was 100 nm. For absolute value determination of the Young’s Modulus,
each single FD curve was fitted with the Hertz model, the tip was approxi-
mated as spherical and with a radius of 30 nm. Comparisons between the
different cumulative distributions were performed by the Kolmogorov–
Smirnov test. A P-value <0.05 was considered statistically significant. SPT
data were collected from 10 cells from three independent experiments.
Results
D76N b2M aggregation and biophysical
characterization of the aggregates
Given the high amyloidogenic propensity of D76N b2M, in vitro
aggregation of the protein was initiated at 37°C in PBS at a concentra-
tion of 20 lM under vigorous shaking. Aliquots of the mixture were
withdrawn at different time intervals since the beginning of the aggre-
gation reaction, and a number of biophysical properties of the aggre-
gates found in the mixture were investigated (Fig. 1). At the
beginning of the aggregation reaction, D76N b2M exhibited a hydro-
dynamic diameter of 3.7  0.5 nm, as assessed by DLS measure-
ments (Fig. 1A). This value is in agreement with that (3.64 nm)
expected for a compactly folded monomeric protein of 99 residues
[13]. The CD spectrum of the sample showed a single negative peak
at 218 nm, confirming the presence of a prevalently native-like b-fold,
which was retained during the first 24 hrs since the beginning of
aggregation (Fig. 1A, inset). Furthermore, at the beginning of the
reaction, the protein was unable to bind amyloid reporting dyes, such
as Thioflavin-T (ThT, Fig. 1B) and Congo Red (CR, Fig. 1C) as well as
ANS (Fig. 1D). Transmission electron microscopy images confirmed
the absence of any aggregated material at the beginning of the reac-
tion (Fig. 1E). However, ThT fluorescence measurements showed
that, after a lag-phase of ca. 9.5 hrs, the emission of the dye in the
presence of the aggregating D76N b2M increased, reaching a plateau
after around 36 hrs (Fig. 1B). A 18.8-hr half-time, as estimated from
best fits of experimental data to Equation (1), was calculated for the
process. The spectroscopic and microscopic investigation and the
DLS measurements of the species populated at 24 hrs revealed a
heterogeneous population of multimers with hydrodynamic radii in
the 100–300 nm range (Fig. 1A) in the absence of any fibrillar com-
ponent (Fig. 1E); these assemblies were able to bind ThT (Fig. 1B),
ANS (Fig. 1D) and, in part, CR as confirmed by the presence of the
peak at 570 nm (Fig. 1C). Fibrils started to appear after 72 hrs of
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incubation under our aggregation conditions (Fig. 1E) and the species
populated at 144 hrs reached the highest values of hydrodynamic
diameter (Fig. 1A). These fibrils were still able to bind ThT (Fig. 1B)
and exhibited a marked increase in CR binding (Fig. 1C) and a
decrease in ANS binding (Fig. 1D). At these time points, the TEM
images revealed the presence of bundles of unbranched fibrils with a
diameter of about 20 nm (Fig. 1E a, b). Fibril formation after 72 hrs
made it impossible to record CD spectra for such species, because
light scattering by protein aggregates made the spectra too noisy
(data not shown). Taken together, these data show lead to conclude
Fig. 1 Biophysical characterization of in vitro D76N b2M aggregation. In all panels, the colour ranges from red (0 hr) to blue (144 hrs) as time pro-
ceeds since the beginning of the aggregation reaction. (A) Size distributions of D76N b2M at three different time intervals: 0 hr (red), 24 hrs (ma-
genta) and 144 hrs (blue). The inset shows the far-UV CD spectrum recorded for the sample at 0 hr and 24 hrs. (B) Aggregation of D76N b2M
followed by means of ThT fluorescence. The continuous line represents the best fit of experimental data to Equation (1). (C) CR absorption spectra
in the presence of aggregating D76N b2M after 0 hr (red), 24 hrs (magenta) and 144 hrs (blue) since the beginning of the aggregation reaction. In
each case, the continuous line represents CR absorption in the presence of the protein, whereas the dashed line represents protein scattering in the
absence of CR. The black continuous line represents CR absorption in the absence of the protein. The inset shows the difference spectra. (D) ANS
fluorescence during aggregation of the protein. (E) TEM images of samples containing D76N b2M after 24, 72 and 144 hrs since the beginning of
the aggregation. Bar 0 hr: 0.5 lm; bars 24 and 72 hrs: 200 nm; inset 1 = 50 nm; inset 2 = 100 nm; bars 144 hrs: (a) 200 nm, (b) 1 lm.
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that, under our conditions, D76N b2M converts from an initial fully
soluble, folded and monomeric state into insoluble fibrillar assemblies
exhibiting tinctorial properties typical of amyloid aggregates. The pro-
cess occurs via the transient formation of self-assemblies that bind
ThT and ANS and display solvent-exposed hydrophobic patches
responsible for the formation of large clusters (Fig. 1E).
D76N aggregates induce alteration of Ca2+ and
ROS levels leading to necrotic death
We also investigated whether the species transiently populated along
the aggregation path of D76N b2M were toxic and, if so, whether toxi-
city was associated to membrane binding and/or aggregate internal-
ization. The cytotoxicity in our cell model was studied using human
SH-SY5Y neuroblastoma cells previously shown to be sensitive to the
toxicity of 20 lM b2M aggregates [23]. To this aim, human SH-SY5Y
cells were exposed for 24 hrs to 5.0 lM D76N b2M aggregates
(monomer protein concentration) grown for different times under our
aggregation conditions; then, aggregate cytotoxicity was evaluated by
the MTT assay. When compared to the exposure of cells to mono-
meric D76N b2M, the cytotoxicity of early aggregates was very low;
significant toxicity values started to appear in cells exposed to aggre-
gates aged 72 hrs and reached the highest values in cells exposed to
samples aged 120 or 144 hrs (Fig. 2A). In addition, the significant
cytotoxic effect of 144-hr sample on SH-SY5Y cells resulted at the
concentration of 5.0 lM and 8.0 lM (Fig. 2B). These data match the
presence of fibrillar material, suggesting that cytotoxicity is associ-
ated with fibrils. Our data agree with previous studies showing a dose
dependence of the cytotoxic effect of the wild-type b2M in the 1- to
20-lM concentration range and an IC50 value around 4.6 lM [23]. In
addition, comparable levels of cytotoxicity were observed for early
aggregates of D76N b2M and wild-type b2M oligomers [23]. Similar
levels of cytotoxicity were observed on the mouse cardiac cell line
HL-1 treated for 24 hrs with 5.0 lM D76N b2M aggregates
(Fig. S2C) reinforcing the role of this b2M variant in the onset of a
systemic amyloidosis [4]. Next, we sought to provide information on
the mechanisms of cell damage following exposure to toxic D76N
b2M aggregates by measuring intracellular free Ca2+ and ROS levels
using the fluorescent probes Fluo-3-acetoxymethyl ester (Fluo-3AM)
and CM-H2DCFDA, respectively. Figure 2C shows a twofold and a
sevenfold increase of the intracellular Ca2+ concentration in cells trea-
ted for 1.0 hr with 5.0 lM D76N b2M aggregates aged 72 or
144 hrs, respectively, whereas no significant changes were observed
when the cells were treated for 1.0 hr with vehicle (PBS) or with pro-
tein samples obtained at early aggregation times (up to 24 hrs), in
agreement with the MTT data. Since derangement of intracellular free
Ca2+ levels and ROS production are biochemically related parameters,
we also measured the amount of ROS levels in SH-SY5Y cells treated
with D76N b2M samples aggregated for different time periods.
Figure 2D shows that ROS levels increased in cells exposed to
increasingly aged D76N b2M. The highest ROS increase (3.5-fold with
respect to untreated cells) was observed after cell treatment with the
most toxic, 144-hr-aged aggregates, in agreement with the free Ca2+
and MTT results. The same results were obtained with HL-1 cells
(Fig. S2D) confirming that the 144-hr-aged aggregates were the most
aggressive form.
Finally, we investigated whether the aggregate-exposed cells
underwent death and whether the latter was of necrotic or apoptotic
type, considering that apoptosis and necrosis can both be triggered
by amyloid aggregates [24]. SH-SY5Y cells were treated for 24 hrs
with the most toxic, 144-hr-aged, D76N b2M aggregates and then
labelled with FITC-conjugated Annexin V, a specific dye that detects
phosphatidylserine externalization (as a marker of apoptosis), and PI
that labels the cellular DNA in necrotic cells. Such a double labelling
allowed us to differentiate early apoptotic cells (Annexin V-positive,
PI-negative), necrotic cells (Annexin V-negative, PI-positive) and fully
viable cells (Annexin V-negative, PI-negative). Figure 2E shows that
8.4% of the cells treated with the aggregates were Annexin V-negative
but IP-positive, confirming the occurrence of necrotic death rather
than the induction of the apoptotic pathway.
Interaction with the cell membrane is required
for aggregate cytotoxicity
It is widely reported that a main mechanism of amyloid aggregate cyto-
toxicity requires the primary interaction between the aggregates and
the cell membrane, resulting in functional and/or structural perturba-
tion of the latter. To investigate the ability of variously aged D76N b2M
aggregates to interact with the cell membrane of the exposed cells, we
performed confocal microscopy experiments using both a polyclonal
antibody raised against recombinant b2M and Alexa 488-conjugated
CTX-B, a probe specific for the monosialotetrahexosylganglioside 1
(GM1), a common lipid raft marker widely reported as a key interaction
site for amyloids [25–28]. We imaged the presence of clusters of all
aggregates onto the plasma membrane of SH-SY5Y cells (Fig. 3A–C),
suggesting co-localization with GM1. A FRET analysis was performed
to confirm the interaction between GM1 (green) and aggregates (red).
However, we observed a high FRET efficiency, particularly for the 144-
hr-aged aggregates (Fig. 3, 3a), whereas the FRET was completely
absent in samples aggregates for 24 hrs (Fig. 3, 1a), suggesting a dif-
ferent way of interaction with the cell membrane of differently aged
aggregates. It was not evident any internalization of 144-hr-aged
aggregates in cells exposed for 24–48 hrs (data not shown), indicating
that the toxic effect of these aggregates occurs without internalization.
The GM1-D76N b2M interaction was confirmed also with HL-1 cells
(Fig. S2A and B) treated with 24- or 144-hr-aged samples. We
observed a high efficiency of FRET also for sample aged 24 hrs, con-
firming the multisystem onset of the disease in vivo [4]. This is in
agreement with the different cell susceptibility to toxic protein aggre-
gates based on the efficiency of different cell types to accumulate amy-
loid precursors at their plasma membrane [29].
GM1 depletion decreases the toxicity of D76N
b2M aggregates
In another set of experiments, we sought to confirm that aggregate
toxicity resulted from their ability to interact with the cell membrane
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at GM1-enriched sites and hence was dependent on the presence of
GM1 in the membrane itself. To this purpose, we modified the gan-
glioside content in the membrane by pre-treating the cells with
25 lM PDMP, a glucosylceramide synthase inhibitor that blocks the
natural synthesis of GM1 [17]. The resulting reduction by about two-
fold of the GM1 content in the plasma membrane (Fig. 4A) left cell
viability unaffected (Fig. 4F). As expected, aggregate binding to GM1-
depleted cells exposed for 24- to 144-hr-aged D76N b2M aggregates
was significantly reduced (Fig. 4B and C), as confirmed by the
reduced FRET efficiency (Fig. 4D and E); moreover, cell vulnerability
to the aggregates was also suppressed (Fig. 4F). These data lend fur-
ther support to the importance of GM1 as a major membrane binding
site for amyloid fibrils [25].
D76N b2M amyloid aggregates alter GM1 lateral
diffusion
Single particle tracking experiments were performed to confirm the
interaction between GM1 and D76N b2M aggregates aged 144 hrs
at the plasma membrane of SH-SY5Y cells. This technique exploits
fluorescent semiconductor nanocrystals, QDs, as a very bright and
photostable probe to follow the motion of membrane molecules
such as lipids and proteins with nanometric resolution in living
cells [18]. The cells were incubated for 20 min. with aggregates of
D76N b2M aged 144 hrs and labelled with anti-b2M/antimouse
Alexa 488 and CTX-B/QDs 655 (Fig. 5A). At these conditions, D76N
b2M aggregates did not diffuse significantly during the recording
sessions of 2.5 sec. Then, the GM1 molecules were discriminated
according to the localization of their trajectories with respect to the
aggregates (Fig. 5B). The linear average MSD plot of GM1 mole-
cules moving across regions away from D76N b2M aggregates
reflected a typical Brownian motion (Fig. 5C). By contrast, the GM1
molecules co-localizing with D76N b2M aggregates displayed a
curved average MSD plot that can be ascribed to a confined type
of motion (Fig. 5C). Furthermore, the cumulative distributions of
diffusion coefficients (D) of single GM1 molecules moving over and
separately from D76N b2M aggregates differed substantially
(Fig. 5D). The median D value of GM1 molecules overlapping with
D76N b2M aggregates was one order of magnitude lower (Table 1).
The median D value of freely diffusing GM1 appeared higher than
those reported previously [25, 26] 1.2 9 101 lm2/sec. with
respect to 2.9 9 102 lm2 sec. and 2.7 9 102 lm2/sec. This
discrepancy is possibly due to the higher acquisition frame rate
used here (100 Hz as compared with 3 Hz). Nevertheless, the
absolute value of the change of GM1 D in the presence of D76N
b2M aggregates was comparable to that observed in the presence
of Ab1-42, amylin and Sup35pNM amyloid aggregates [25–28].
Overall, these data show at the single molecule level that the mobil-
ity of GM1 in living neuroblastoma cells is altered by b2M aggre-
Fig. 2 Cytotoxicity of D76N b2 m aggregates. (A) MTT assay of SH-SY5Y cells exposed for 24 hrs to 5.0 lM D76N b2M samples aggregated for dif-
ferent times. (B) Dose-dependent effect of 144-hr-aged D76N b2M on SH-SY5Y viability. (C) Confocal microscopy imaging of intracellular free Ca2+
levels in SH-SY5Y cells exposed for 1.0 hr to 5.0 lM D76N samples aggregated for 24, 72 or 144 hrs. Right: quantification of Ca2+ levels with
respect to untreated cells. (D) ROS production in SH-SY5Y cells exposed for 24 hrs to D76N samples (5.0 lM) aggregated for varying lengths of
time. Error bars in all bar plots indicate the standard deviation of three independent experiments carried out in triplicate. T-test analysis:
*P < 0.005; **P < 0.001;***P < 0.0001 versus untreated cells. (E) FACS analysis of cells treated with D76N b2M aggregates aged 24, 72 or
144 hrs. The plots show the scatter dot plots of Annexin V FITC-A versus propidium iodide. The percentages of gated cells in the two populations
are also reported.
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gates, further supporting the idea that this lipid is a key interaction
site even for the aggregates formed by this protein.
D76N b2M aggregates interact specifically with
synthetic lipid bilayers enriched in GM1
To confirm, and get further insights on the aggregate-membrane
interaction, we also investigated by AFM imaging and elasticity mea-
surements whether aggregate binding affected the physical properties
of synthetic lipid bilayers. D76N b2M aggregates were administered
to synthetic lipid bilayers with two different lipid mixtures (DOPC:
SM:chol:GM1 and DOPC:SM:chol), as described in Materials and
Methods. The morphology and elasticity of the bilayers were
assessed before and after addition of the aggregates. Both lipid mix-
tures assembled into a lipid bilayer with two distinct lipid phases. The
thicker domains correspond to the ordered lipid phase (LO) that,
under our conditions, was enriched in cholesterol, sphingomyelin and
GM1, when present. The rest of the sample represents the disordered
phase domain (LD), where the DOPC is the main component [30].
The difference in eight between LO and LD domains was
2.2  0.6 nm in the presence of GM1 and 0.6  0.3 nm in the
absence of GM1 (Fig. 6A and D). Figure 6G and J reports typical
height distributions in both cases. The calculation of the elasticity
maps revealed that Young’s moduli (E) of the two phases were clearly
distinct in the sample containing GM1 (Fig. 6M and S), while they
were quite similar in the samples without GM1 (Fig. 6P and V). The
aggregates grown for 1.0 hr induced a weak destabilization of the
bilayers containing GM1 (Fig. S1I and M). Under these conditions,
the morphology of the two lipid phases appeared essentially unmodi-
fied, the difference in height between the two phases being only
slightly changed (2.4  0.4 nm) and the two domains being still
clearly distinguishable, yet with the presence of a few small defects
(Fig. S1A and E). A global decrease of membrane rigidity was mea-
sured in the GM1-enriched domains compared to the untreated bilay-
ers, where a shift towards reduced values of elasticity was evident
(Fig. S1I and M). The aggregates aged 24 hrs induced a more
marked perturbation of the membrane structure. Accumulation of
material on the LO domains was clearly detected (Fig. 6B, arrow) as a
new peak in the height distribution (labelled as PA in Fig. 6). This was
not compatible with the formation of a second lipid bilayer on the top
of the first one, both in terms of thickness and of elasticity (Fig. 6H,
N, T). In particular, the distribution of elasticity confirmed that mem-
brane integrity was still maintained in most of the bilayer area (see
peaks LD and LO in Fig. 6T). However, portions of the sample charac-
terized by a significantly lower stiffness (and hence located at lower E
values in the distribution in Fig. 6T) were present, and these were
associated with the presence of the additional material at the surface
A B C
Fig. 3 Immunolocalization of D76N b2M
aggregates onto the plasma membrane.
SH-SY5Y cells exposed for 24 hrs to
5.0 lM D76N b2M aggregated for 24 hrs
(A), 72 hrs (B) or 144 hrs (C). The cells
were stained with Alexa 488-conjugated
CTX-B (green fluorescence); protein
aggregates were stained with anti-b2M
antibodies followed by treatment with
Alexa 568-conjugated anti-rabbit sec-
ondary antibodies (red fluorescence).
FRET efficiency is shown in 1a, 2a, 3a for
aggregates aged 24, 72 or 144 hrs,
respectively.
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of the bilayer, possibly consisting of protein aggregates or complexes
formed upon mixing of protein aggregates with sequestered lipids.
After the administration of 144-hr-aged aggregates, the morphologi-
cal and structural features associated with the LO domains were com-
pletely lost (Fig. 6C and I). Under these conditions, islands of
material characterized by a higher roughness and thickness with
respect to the intact LO phases were distributed all over the mem-
brane (Fig. 6C). The peak at 2.2 nm, characteristic of the LO phase,
was completely replaced by the PA peak after the interaction with
aggregates aged 144 hrs (Fig. 6I). These domains were also charac-
terized by a low E value (Fig. 6O and U), compatible with that
observed with aggregates aged 24 hrs (Fig. 6B). Under these condi-
tions, the elasticity peak associated to the LD phase was still pre-
served, indicating that the latter was substantially unaffected,
possibly due to the weak interaction between protein assemblies and
DOPC bilayer. All these findings lend support to the idea that D76N
b2M aggregates are recruited onto the LO phase, confirming the
importance of GM1 in aggregate recruitment. Substantially superim-
posable results were observed for aggregates aged 72 hrs (Fig. S1B,
F, J and N). To further confirm the specific role played by GM1, the
same protein aggregates were administered also to lipid bilayers lack-
ing GM1. In this case, membrane morphology was maintained follow-
ing administration of aggregates grown for 1 hr (Fig. S1C, G, K and
O), 24 hrs (Fig. 6E, K, Q and W), 72 hrs (Fig. S1D, H, L and P) or
144 hrs (Fig. 6F, L R and X). Both the LD and the LO phases were
preserved and protein aggregates did not accumulate onto the mem-
brane. In this case, the elasticity analysis was complicated by the
overlap between the E distributions associated with the two phases.
Nevertheless, a global decrease of stiffness was detected as a conse-
quence of GM1 depletion, but the shape of the distribution was essen-
tially unaltered following addition of the aggregates, indicating the
absence of selective perturbations in either phase.
Discussion
D76N b2M is the first described genetic variant of b2M associated
with a familial form of systemic amyloidosis. The protein displays a
stronger amyloidogenic propensity with respect to the wild-type
form and aggregates easily in vitro in PBS. The determination of
the three-dimensional structure and the mutation-related behaviour
of this variant have provided valuable information about the molec-
ular basis of D76N b2M aggregation [4, 10]. In spite of this infor-
mation and the interest raised by the discovery of this b2M variant
in the population, little is known about its aggregation path, its abil-
ity to interact with synthetic and biological membranes and the
molecular mechanisms of aggregate cytotoxicity. In the present
study, we aimed to provide knowledge on these issues by exploit-
ing a battery of complementary biophysical techniques and cell biol-
ogy methods.
It has been long recognized that the unstable, heterogeneous pre-
fibrillar assemblies transiently populated during the early phases of
in vitro aggregation of many different proteins are the main culprit of
amyloid-related toxicity [31]. Conversely, although the fibrils are
considered stable, they can still act as reservoirs of toxic species [32,
33]. Furthermore, when such species are added to cultured cells, their
specific interaction with the cell membrane could induce fibril frag-
mentation leading to new or enhanced, deleterious, biological
A
F
B C
D E
Fig. 4 GM1 levels are associated with cell susceptibility to D76N b2M aggregate toxicity. (A) Confocal imaging of SH-SY5Y cells untreated or treated
with PDMP and stained with CTX-B/Alexa 488 (top) and quantification of the corresponding fluorescence signal (bottom) (B–E) Immunolocalization
(B and C) efficiency of FRET between CTX-B/Alexa 488 (GM1) and anti-b2M/Alexa 568 (D and E) in cells pre-treated for 72 hrs with 25 lM PDMP
(C and E) and then exposed for 24 hrs to D76N aggregates aged 144 hrs. (F) MTT assay carried out with SH-SY5Y cells pre-treated for 72 hrs with
PDMP and then exposed for 24 hrs to 5.0 lM aggregates aged 144 hrs. Error bars indicate the standard deviation of three (F) or five (A) indepen-
dent experiments. T-student analysis: *P < 0.005; **P < 0.001; ***P < 0.0001 versus pre-treated with PDMP (F) or versus untreated (A) cells.
10 ª 2016 The Authors.
Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.
responses; similar findings were previously reported for wild-type
b2M [33, 34]. In addition, aberrant surface properties of amyloid spe-
cies may influence their toxicity; these include the presence of
hydrophobic patches that may act as sticky sites promoting aberrant
interaction of amyloid assemblies with the cells or, alternatively,
aggregate clumping. Our DLS and TEM analysis showed that under
our conditions, D76N b2M fibrillar aggregates aged 144 hrs were the
most toxic species, while aggregates obtained at earlier incubation
times were composed of non-fibrillar, spheroidal species with a high
tendency to associate and to form clumps. We found that the fluores-
cence intensity of ANS in the presence of these early species was
higher than that recorded in the presence of the 144-hr-aged cyto-
toxic assemblies. Given that all the samples aged up to 24 hrs exhib-
ited the same content of b-structure, as assessed by ThT, CR and CD
spectra, indicating an already established amyloid-like conformation
(Fig. 1A), the hydrophobic side chains of the aged samples were
expected to be less accessible to ANS than those of samples aggre-
gated for shorter times, presumably due to a different packing of the
protofilaments. When moved to a cell growth medium, these fibrillar
samples interacted with the cell membrane, preferentially with nega-
tively charged species such as the sialic acid of GM1, suggesting that
such interaction does not involve hydrophobic patches but, rather,
electrostatic interactions.
It is likely that the interaction between aggregates obtained after
144 hrs of incubation and membrane surfaces results in membrane
damage and cytotoxicity through a mechanism involving the release
of cytotoxic species, as hypothesized elsewhere [35]. This idea was
corroborated by a poorly scattered signal around larger D76N b2M
aggregates in the FRET analysis.
The observations arising from our study raise the possibility that
the toxicity of protein aggregates is not necessarily related to the oli-
gomeric nature but rather to structural and surface properties that
may or may not be shared by early and late aggregates. Our findings
showed that differently from many other aggregating peptides and
proteins, the mature aggregates of D76N b2M displayed the most
severe cytotoxic effects, in agreement with the damage induced by
wild-type b2M fibrils [36], whereas the aggregation intermediates,
including early aggregates, commonly considered most cytotoxic,
were indeed less cytotoxic. This finding, albeit unusual, is not entirely
surprising since in several cases fibrils toxicity eventually culminating
with necrotic cell death, as in our case, has been reported [37–39].
Our toxicity results were coherent with the other investigated features
of the D76N b2M pre-fibrillar aggregates and fibrils, including their
Fig. 5 D76N aggregates affect GM1 mobility in living SH-SY5Y neu-
roblastoma cells. (A) Imaging of single GM1 molecules labelled with
biotin-CTX-B coupled to streptavidin-QD 655 (magenta) and 144-hr-
aged D76N b2M aggregates labelled with anti-b2M and secondary
Alexa 488-conjugated antibodies (cyan). The scale bar corresponds to
2.0 lm. (B) Trajectories of the GM1 molecules in the proximity of
(magenta), or overlapping (grey) the D76N b2M aggregates (cyan). (C
and D) Average mean square displacement and cumulative probability
distributions of the diffusion coefficients of GM1 molecules classified
as over (grey) and apart from (magenta) D76N b2M aggregates.
Table 1 Analysis of GM1 lateral diffusion in the presence or in the absence of D76N b2M aggregates
Condition n Dmedian (lm
2/sec.) Dmax* P
†
GM1-CTX-B out D76N b2M 33 1.2 9 101
GM1-CTX-B over D76N b2M 25 2.1 9 102 6.8 9 101 ≤104
*Maximum difference in cumulative fraction between GM1-CTX-B diffusion over and nearby D76N b2M aggregates.
†Kolmogorov–Smirnov test P-value calculated using Dmax as statistic.
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ability to interact with synthetic and biological membranes. When
incubated with cells, these samples interacted with the cell membrane
preferentially in regions enriched in GM1, possibly through its nega-
tively charged sialic acid residue, as shown for many other amyloid
systems [25, 26]. This suggested that such interaction was mediated
predominantly by electrostatic interactions. The key role played by
GM1 in aggregate recruitment was also confirmed by our FRET exper-
iments, showing a close proximity between D76N b2M aggregates
and GM1 on the cell membrane. In addition, QD experiments evi-
denced a remarkable alteration of the type of motion of GM1 on the
cell membrane in the absence (Brownian) or in the presence (con-
fined) of the aggregates, further confirming the strict relationship
between aggregates and GM1 and adding to a huge body of studies
that support the importance of GM1 not only as a key aggregate
nucleation site [40, 41] but also as a major aggregate interaction site
on the cell membrane [42]. Considering that biochemical modifica-
tions such as alterations of intracellular free Ca2+ and ROS levels are
amongst the earliest modifications associated with the membrane
perturbations that underlie cell suffering in aggregate-exposed cells,
our data further support the establishment of GM1-aggregate interac-
tion as a key switch of amyloid cytotoxicity. Our measurements with
AFM in QI mode on model membrane reconstructed on a mica sur-
face further support previous results and, in addition, confirm GM1
interaction as an event required for cytotoxicity. Furthermore, these
data point to possible toxicity mechanisms based on a perturbation of
the elasticity (E) of specific (GM1 enriched) ordered lipid phases (LO)
following aggregate interaction with the cell membrane, as observed
for other amyloid-related damaging systems [43, 44]. Such results
also indicate that there is a clear progression in the capability of
D76N b2M aggregates to damage synthetic membranes after 1, 24,
72 and 144 hrs of aggregation, the effect being not observable after
1 hr, significant just after 24 and maximal at 72 and 144 hrs.
Although the evaluation of E for extremely thin layers of soft materials
lying on rigid substrates is still considered a challenging task, we
A B C D E F
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Fig. 6 AFM topography and elasticity maps of lipid bilayers obtained from QI mode measurements. Morphology of lipid bilayers enriched in GM1(5%)
before the interaction with D76N b2M (A) or after the interaction with aggregates of 5.0 lM D76N b2M aged 24 hrs (B) or 144 hrs (C). The white
arrows show accumulated protein aggregates; the red ‘x’ marks the absence of LO phase. The morphology of lipid bilayers lacking GM1 (D) was not
altered upon interaction with protein aggregates aged 24 hrs (E) or 144 hrs (F). Height distributions in the presence (G–I) or in the absence (J–L) of
GM1. Elasticity maps in the presence (M–O) or in the absence (P–R) of GM1 and the corresponding Young’s modulus distributions (S–U and V–X).
LO: ordered lipid phase; LD: disordered lipid phase; PA: peak corresponding to the signal arising upon accumulation of aggregates onto LO.
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obtained extremely reproducible results, which also agree with
those obtained, by means of a similar approach, by Picas and
co-workers [45].
In conclusion, our data provide a first glimpse on the aggrega-
tion path, membrane interaction and cytotoxicity of the only known
b2M variant associated with a familial form of systemic b2M amy-
loidosis. Further investigations will define more precisely the
molecular and environmental players affecting D76N b2M aggrega-
tion in tissues, the molecular details and the biochemical and cell
biology modifications that underlie the physiological effects of
those species. When added to those pertaining wild-type b2M,
these data will aid depicting more precisely the scenario of b2M
deposition, providing clues for the search of molecules and
treatments aimed at tackling the pathologies associated with this
phenomenon.
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Figure S1 AFM topography and elasticity maps of lipid bilayers
obtained from QI mode measurements. Morphology of lipid bilayers
enriched in GM1 (5%) in presence of aggregates of 5.0 lM D76N b2M
aged 1 hr (A) or 72 hrs (B). The white arrows show accumulated pro-
tein aggregates; the red ‘x’ marks the absence of LO phase. The mor-
phology of lipid bilayers lacking GM1 was not altered upon interaction
with protein aggregates aged 1.0 hr (C) or 72 hrs (D). Height distribu-
tions in the presence (I and J) or in the absence (K and L) of GM1. Elas-
ticity maps in the presence (M and N) or in the absence (O and P) of
GM1 and the corresponding Young’s modulus. LO: ordered lipid
phase; LD: disordered lipid phase; PA: peak corresponding to the sig-
nal arising upon accumulation of aggregates onto LO.
Figure S2 Cytotoxicity of D76N b2M aggregates on HL-1 cells. (A
and B) HL-1 cells exposed for 24 hrs to 5.0 lM D76N b2M aggre-
gated for 24 hrs (A) and 144 hrs (B). The cells were stained with
Alexa 488-conjugated CTX-B (green fluorescence); protein aggregates
were stained with anti-b2M antibodies followed by treatment with
Alexa 568-conjugated anti-rabbit secondary antibodies (red fluores-
cence). FRET efficiency is shown in panels 1, 2 for aggregates aged
24 hrs or 144 hrs, respectively. (C) MTT assay on HL-1 cells exposed
for 24 hrs to 5.0 lM D76N b2M samples aggregated for different
times. (D) ROS production in HL-1 cells exposed for 24 hrs to D76N
samples (5.0 lM) aggregated for varying lengths of time. Error bars
in all bar plots indicate the standard deviation of three independent
experiments carried out in triplicate. T-test analysis: *P < 0.005;
**P < 0.001;***P < 0.0001 versus untreated cells.
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